The settlement also says Teva will supply the city with $20 million worth of generic Narcan, the brand name for a nasal spray used for opioid overdoses, over the next decade. Teva said the decision to settle “is not an admission of any liability or wrongdoing.”
From January to May, Teva has settled opioid cases with four states for about $378 million, according to Bloomberg.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
